Clinical trial
Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the…
NCT00066716 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00066716 |
|---|---|
| Title | Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus |
| Official title | A Phase II Study Of Preoperative Celecoxib/Paclitaxel/Carboplatin For Squamous Cell And Adenocarcinoma Of The Esophagus |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, celecoxib, paclitaxel, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Enrollment | 39 |
| Start date | Jun 1, 2003 |
| Primary completion | May 1, 2007 |
| First posted | Aug 7, 2003 |
| Last update posted | Dec 8, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: